They’ve been implicated in health concerns, including cancer, thyroid disease, liver damage, fertility problems, and immune system disorders, as well as increased cholesterol levels, obesity ...

Orionis Biosciences, a privately held company, announced a second multi-year collaboration with Genentech, a member of the Roche Group (OTCQX:RHHBY) on Wednesday. The goal of this partnership is ...

She added: “For three decades, Roche Bermuda and Bermuda College have worked hand in hand to open doors for Bermudians. “These awards honour that history while looking boldly to the future.

Roche Bermuda has awarded three $10,000 scholarships to graduating students at Bermuda College. A spokesperson said, “This historic contribution comes as Roche Bermuda celebrates its 30-year ...

Roche’s assay is crucial for individuals to be considered for treatment with AbbVie’s Emrelis. Credit: Marlon Trottmann / Shutterstock. The US Food and Drug Administration (FDA) has granted approval ...

The FDA has also approved Roche Holdings AG’s RHHBY VENTANA MET (SP44) RxDx Assay, the only IHC companion diagnostic identifying patients eligible for Emrelis treatment. On Wednesday ...

Roche Holding AG said it would need to reconsider planned US investments if President Donald Trump implements an executive order to cut prescription drug costs. Last month, Roche said it planned ...

Roche Says Trump's Drug Price Order Threatens Its $50 Billion US Investment Plans By Maggie Fick LONDON (Reuters) - U.S. President Donald Trump's executive order on drug pricing threatens Roche's ...

For people with early-stage HER2-positive disease, the APHINITY results validate the sustained benefits of the Perjeta-based regimen,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer ...

Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems. The news comes on the heels of an announced $700 million investment in North ...

In parallel with approving AbbVie's antibody-drug conjugate (ADC), the agency also approved Roche's Ventana MET (SP44) RxDx Assay for identifying patients with c-Met overexpression who are eligible ...